LiveRamp Holdings, Inc.·4

May 19, 6:55 PM ET

Karasick Matthew 4

4 · LiveRamp Holdings, Inc. · Filed May 19, 2026

Research Summary

AI-generated summary of this filing

Updated

LiveRamp (RAMP) CPO Matthew Karasick Receives RSU Award

What Happened

  • Matthew Karasick, Chief Product Officer of LiveRamp Holdings, was granted 38,961 restricted stock units (RSUs) on May 15, 2026. The RSUs have no purchase price (reported at $0) and represent a contingent right to receive one share of common stock per RSU upon vesting. This is an award grant (not a purchase or sale) and does not by itself indicate buying or selling activity.

Key Details

  • Transaction date: May 15, 2026; Form 4 filed May 19, 2026 (filed 4 days after the transaction).
  • Grant size: 38,961 RSUs; reported acquisition price: $0.00.
  • Shares owned after the transaction: not specified in the filing.
  • Footnote (F1): RSUs granted under the 2005 Equity Compensation Plan. Vesting: 1/3 vests on May 22, 2027; remaining shares vest in equal quarterly installments on the 22nd of each applicable month thereafter until fully vested, subject to continued employment.
  • Transaction type code: A = Award/Grant.

Context

  • RSUs are compensation awards that convert to shares upon vesting; they are commonly used to retain executives and align incentives with shareholders. Because this is a grant (not a market purchase), it should be viewed as part of executive compensation rather than an immediate bullish market signal.
  • The filing occurred four days after the transaction date; Form 4s are generally required within two business days of the transaction, so investors may note the delayed filing.

Insider Transaction Report

Form 4
Period: 2026-05-15
Karasick Matthew
CHIEF PRODUCT OFFICER
Transactions
  • Award

    COMMON STOCK, $.10 PAR VALUE

    [F1]
    2026-05-15+38,961129,440 total
Footnotes (1)
  • [F1]These restricted stock units ("RSUs") are granted pursuant to the registrant's 2005 Equity Compensation Plan. Each RSU represents a contingent right to receive one share of the registrant's common stock. Vesting will take place over three years from the date of grant, with 1/3 of the shares scheduled to vest on May 22, 2027, and the remainder vesting in equal quarterly amounts thereafter on the 22nd day of the applicable month until 100% vested, contingent upon the recipient's continued employment with the registrant.
Signature
/s/ BY: JERRY C. JONES, ATTORNEY-IN-FACT FOR: MATTHEW KARASICK|2026-05-19

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT